Navigation Links
Nationwide product launch of NKO(R) planned for February 2008 in Australia and New Zealand
Date:12/19/2007

- Neptune Technologies & Bioressources Inc. enters into an exclusive distribution agreement with AZPA International Inc. for Australia and New

Zealand -

LAVAL, QC, Dec. 19 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) is pleased to announce that it has entered into an exclusive distribution agreement with AZPA International Inc. ("AZPA International") for Australia and New Zealand. AZPA International, a leading supplier to the pharmaceutical, nutritional health and cosmetics industries, has also acquired non-exclusive rights to commercialize Neptune's products in Southeast Asia and Hong Kong.

The nationwide product launch of Neptune Krill Oil (NKO(R)) in Australia and New Zealand, claiming cardiovascular and joint health benefits, is scheduled for February 2008. A pre-requisite for commercializing NKO(R) in Australia hence New Zealand is obtaining approval as a complementary medicine from the Therapeutic Goods Administration (TGA) which notification Neptune has recently announced.

AZPA International joined forces for the commercialization and distribution of NKO(R) with PharmaLink Pte. Ltd. ("PharmaLink"), a leading provider of complementary and over-the-counter medicines and a leader in healthcare sales and marketing in the Asia-Pacific region. PharmaLink will be reaching the market through its primary care team, its pharmacy/ OTC team and its specialist/ allied health team.

"It is estimated that 74% of the Australian population has used complementary medicine in the previous twelve months and usage rates are expected to rise,(1)" said Thierry Houillon, Vice President of Nutraceuticals of Neptune. "An estimated annual increase of 18% has been reported for the complementary medicine market in Australia.(2) We are looking forward to working with AZPA International and PharmaLink benefiting from this trend and making NKO(R) a household name
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted
2. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
3. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
4. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
5. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
6. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
7. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
8. IsoTis Receives FDA Clearance for Accell Family of Products
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015  Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage ... today announced that it will be presenting at CALBIO ... 2 nd at 3pm PST. Patrick Lucy, chief business ... the current state of the biosimilar industry landscape entitled ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015   Regulus ... biopharmaceutical company leading the discovery and development of innovative ... Xanthopoulos , Ph.D., President and Chief Executive Officer of ... and Company 35 th Annual Healthcare Conference on ... conference is being held at the Boston Marriott Copley ...
(Date:2/26/2015)... , Feb. 26, 2015  NuGene International, Inc. ... products for skin and hair rejuvenation, has announced ... agency of record for investor relations and strategic ... our distribution, sales and diversification strategies – and ... and prospective shareholders," stated Ali Kharazmi CEO of ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3
... LEXINGTON, Mass., Aug. 28 Instrumentation Laboratory,(IL) today ... (FDA) has,granted 510(k) clearance to expand the intended ... thromboembolism (VTE) in outpatients suspected of,deep venous thrombosis ... with a clinical pretest probability (PTP) assessment model.,HemosIL ...
... Agency (ESA) has appointed the UK,s National Physical Laboratory ... group will lead a consortium to identify the next ... used in future space missions. , "Advances in nanotechnology ... Higher Research Scientist in the nanomaterials group at NPL, ...
... LAKES, N.J., Aug. 27 BD (Becton,Dickinson and Company) ... today that it would present at the following investor ... September 4, 2008 1:30 p.m. EDT, Morgan ... 8:00 a.m. EDT, A live webcast of ...
Cached Biology Technology:Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay 2
(Date:2/23/2015)... Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... patent 62114357 for DISTRIBUTED VOICE DIRECTED PAYMENT ... introduces a new groundbreaking payment method. Payment accounts may ... may only be accessed if both the speech (the ...
(Date:2/13/2015)... -- ACT Genomics Co., Ltd., a cancer molecular ... genomic information into precision diagnosis and personalized treatments, ... million in the its first private funding round. ... , ACT Genomics has developed comprehensive cancer ... implement next generation sequencing (NGS) and multiplex molecular ...
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... Children with Duchenne muscular dystrophy (DMD) face a future ... respiratory or cardiac failure before their 30th birthday. While researchers ... effective treatment, few have targeted the heart of the problem ... new $2.1 million grant he received from the National Institutes ...
... Studies on genetically engineered mice show that social stress ... atherosclerosis. Commonly used drugs to reduce blood pressure, however, ... a thesis presented at the University of Gothenburg, Sweden. ... is a correlation between psychosocial stress and the risk ...
... Sledge Jr., M.D., a nationally recognized pioneer in the ... the 2010 William L. McGuire Memorial Lecture Award at ... Supported by GlaxoSmithKline Oncology (GSK) since its inception ... for their significant contributions to breast cancer research. ...
Cached Biology News:New NIH grant helps MU scientist get to the heart of muscular dystrophy 2Social stress leads to atherosclerosis 2George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research 2
...
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
Form: Concentrated Applications: ELISA...
RABBIT ANTI HALOPERIDOL...
Biology Products: